CHEK2 mutations are known to increase breast, ovarian, thyroid, pancreas, colon, prostate, and kidney cancer risk, being considered a multiorgan cancer susceptibility gene (29), with moderate penetrance (47). Here, CHEK2 is linked to kidney cancer.